Polyrizon Secures European Patent Publication EP4751737 for Mucoadhesive Nasal Drug Delivery Technology
PLRZ•Polyrizon’s Trap & Target mucoadhesive polymer technology secured European publication number EP4751737 upon EPO’s technical completion for ‘Mucoadhesive Polymers for Nasal Drug Delivery.’ This milestone bolsters the company’s IP portfolio and underpins potential commercial partnerships across multiple European markets.
1. European Patent Publication
The European Patent Office completed technical preparations to publish Polyrizon’s patent application for “Mucoadhesive Polymers for Nasal Drug Delivery” under publication number EP4751737.
2. Trap & Target Technology Platform
The application covers Polyrizon’s proprietary Trap & Target mucoadhesive polymer system designed to enhance nasal mucosa interaction, increasing formulation retention and drug absorption through a hydrogel-based delivery mechanism.
3. Strategic Growth and Partnerships
This publication milestone strengthens the company’s intellectual property portfolio and supports future examination processes, potentially facilitating commercialization and partnering across multiple European pharmaceutical markets.
